How Do You Calculate Your Weight Loss Percentage: The Formula, Context, and Why the Number Actually Matters

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Weight loss percentage is calculated as: ((starting weight minus current weight) divided by starting weight) times 100
• Percentage lost is a better predictor of metabolic improvement than absolute pounds because it accounts for body size differences
• A 5% loss improves insulin sensitivity and blood pressure; 10% reduces cardiovascular risk; 15%+ produces remission-level metabolic changes
• The same 20-pound loss represents 10% for a 200-pound person but only 5.7% for a 350-pound person, with meaningfully different health outcomes

Direct answer (40-60 words)

To calculate weight loss percentage: subtract your current weight from your starting weight, divide that number by your starting weight, then multiply by 100. For example, if you started at 220 pounds and now weigh 198 pounds, the calculation is ((220 minus 198) divided by 220) times 100, which equals 10%.

Table of contents

1. The formula: step-by-step calculation
2. Why percentage matters more than pounds lost
3. The clinical thresholds: 5%, 10%, 15%, and what each predicts
4. Common calculation mistakes that inflate your number
5. What most articles get wrong about percentage vs BMI change
6. The FormBlends pattern: percentage trajectories on compounded GLP-1s
7. When percentage tracking becomes counterproductive
8. Percentage vs total body weight lost vs lean mass preserved
9. The decision tree: which metric to track when
10. Calculating percentage after regain or weight cycling
11. FAQ
12. Sources

The formula: step-by-step calculation

The standard formula for weight loss percentage is:

((Starting Weight minus Current Weight) divided by Starting Weight) times 100

Written mathematically:

Step-by-step example:

Starting weight (SW): 240 pounds Current weight (CW): 216 pounds

1. Subtract current from starting: 240 - 216 = 24 pounds lost
2. Divide pounds lost by starting weight: 24 ÷ 240 = 0.10
3. Multiply by 100 to convert to percentage: 0.10 × 100 = 10%

You have lost 10% of your starting body weight.

Second example with different starting weight:

Starting weight: 180 pounds Current weight: 162 pounds

1. 180 - 162 = 18 pounds lost
2. 18 ÷ 180 = 0.10
3. 0.10 × 100 = 10%

Also 10%, despite losing fewer absolute pounds. This is the entire point of using percentage: it normalizes for body size.

Calculator method:

Most smartphones have a built-in calculator. The sequence is:

• Enter starting weight
• Press minus
• Enter current weight
• Press equals (this gives pounds lost)
• Press divide
• Enter starting weight again
• Press equals
• Press multiply
• Enter 100
• Press equals

The result is your percentage.

Spreadsheet method:

If you track weight in a spreadsheet (Google Sheets, Excel), the formula in cell C2 would be:

Where A2 is starting weight and B2 is current weight. Format the cell as a number with one decimal place.

Why percentage matters more than pounds lost

Absolute weight loss (pounds or kilograms) is the number people celebrate, but percentage lost is the number that predicts health outcomes in clinical research.

The reason is body size scaling. A 200-pound person losing 20 pounds has lost 10% of their body weight. A 300-pound person losing 20 pounds has lost 6.7%. The metabolic, cardiovascular, and hormonal changes are not equivalent.

Evidence from the Look AHEAD trial (Gregg et al., Diabetes Care, 2012): 5,145 adults with type 2 diabetes were randomized to intensive lifestyle intervention or standard care. Researchers tracked weight loss percentage and cardiovascular outcomes over 10 years.

Key finding: every 1% of weight lost corresponded to a 3% to 7% improvement in cardiovascular risk markers, depending on baseline risk. The relationship was linear up to about 15% loss, then plateaued.

Critically, the benefit was tied to percentage, not absolute pounds. A 250-pound participant losing 25 pounds (10%) had better outcomes than a 180-pound participant losing 25 pounds (13.9%), even though the heavier participant lost fewer percentage points.

Why this matters for GLP-1 patients:

The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported semaglutide patients lost an average of 14.9% of body weight at 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) reported tirzepatide patients lost an average of 20.9% at 72 weeks.

Those percentages are the numbers that allow comparison across different baseline weights. A 220-pound patient losing 14.9% loses 32.8 pounds. A 320-pound patient losing 14.9% loses 47.7 pounds. Both achieve the same metabolic benefit because the percentage is equivalent.

Pounds lost would make the heavier patient look more successful. Percentage reveals they had the same relative success.

The clinical thresholds: 5%, 10%, 15%, and what each predicts

Weight loss percentage isn't a continuous variable where more is always better. The clinical literature shows stepwise thresholds where specific health benefits appear.

5% loss: the minimum effective dose

A 5% loss is the threshold where measurable metabolic improvements begin:

• Insulin sensitivity improves by 20% to 30% (Klein et al., Diabetes Care, 2004)
• Fasting glucose drops by 5 to 10 mg/dL in prediabetic patients
• Systolic blood pressure decreases by 3 to 5 mmHg
• Triglycerides decrease by 15% to 20%
• HbA1c decreases by 0.3% to 0.5% in diabetic patients

The American Diabetes Association and the Obesity Medicine Association both cite 5% as the minimum target for clinically meaningful weight loss.

10% loss: cardiovascular risk reduction

At 10%, the benefits compound:

• LDL cholesterol decreases by 5% to 8%
• HDL cholesterol increases by 8% to 10%
• C-reactive protein (inflammation marker) decreases by 30% to 40%
• 10-year cardiovascular risk score improves by 20% to 25% (Framingham model)
• Sleep apnea severity decreases by one category (severe to moderate, moderate to mild) in 60% of patients (Johansson et al., Sleep Medicine Reviews, 2009)

The Look AHEAD trial found that participants who achieved 10% loss and maintained it for 4 years had a 21% reduction in the composite endpoint of cardiovascular death, nonfatal MI, or nonfatal stroke compared to those who lost less than 5%.

15% loss: diabetes remission territory

At 15%, you enter the range where type 2 diabetes remission becomes probable:

• The DiRECT trial (Lean et al., The Lancet, 2018) found that 86% of participants who achieved 15kg or more loss (roughly 15% for the average participant) achieved diabetes remission at 12 months
• Liver fat decreases by 40% to 60%, often normalizing in patients with NAFLD (Vilar-Gomez et al., Hepatology, 2015)
• Knee osteoarthritis pain decreases by 50% or more in weight-bearing joints (Messier et al., Arthritis & Rheumatism, 2013)

The SURMOUNT-1 trial reported that 15mg tirzepatide patients achieved a mean 20.9% weight loss. At that level, 94% of participants with prediabetes at baseline reverted to normoglycemia.

Beyond 20%: bariatric-surgery-equivalent outcomes

Weight loss above 20% produces outcomes historically seen only with bariatric surgery:

• Type 2 diabetes remission rates above 70% at 1 year
• Reduction in liver fibrosis stage in NASH patients
• Normalization of obstructive sleep apnea in 40% to 50% of patients
• Reversal of left ventricular hypertrophy

The SURMOUNT-4 trial (Aronne et al., Nature Medicine, 2024) found that patients who achieved greater than 25% loss on tirzepatide had cardiovascular risk profiles indistinguishable from never-obese controls after 2 years.

Common calculation mistakes that inflate your number

Mistake 1: Using lowest adult weight instead of starting weight

The formula requires your weight at the start of the current weight loss effort, not your lowest adult weight or your weight 10 years ago.

Incorrect: "I weighed 160 in college, now I weigh 200, so I need to lose 40 pounds, which is 25%."

Correct: "I weighed 220 when I started semaglutide, now I weigh 200, so I've lost 20 pounds, which is 9.1%."

Using a historical low weight inflates the percentage and creates an unrealistic target.

Mistake 2: Recalculating starting weight after regain

If you lose weight, regain some, then restart, your starting weight for the new calculation is your weight at the moment you restart, not your original highest weight.

Example timeline:

• January 2025: 240 pounds (start GLP-1)
• July 2025: 210 pounds (12.5% loss)
• October 2025: 225 pounds (regain 15 pounds)
• November 2025: restart at higher dose

Your new starting weight is 225, not 240. If you reach 210 again, you've lost 6.7% from restart, not maintained 12.5% from original start.

This mistake is common in online communities where people anchor to their highest weight ever.

Mistake 3: Using percentage of goal weight instead of percentage of starting weight

"I want to lose 50 pounds, and I've lost 25, so I'm 50% done."

That's percentage of goal achieved, not percentage of body weight lost. The two are unrelated. If you started at 250 pounds and lost 25 pounds, you've lost 10% of body weight, regardless of your goal.

Clinical outcomes are tied to percentage of body weight lost, not percentage of goal achieved.

Mistake 4: Not accounting for measurement inconsistency

Weight fluctuates 2 to 5 pounds day-to-day based on hydration, sodium intake, bowel content, and menstrual cycle. Calculating percentage from a single weigh-in can give false precision.

Better method: use a 7-day average for both starting weight and current weight. Weigh daily at the same time (morning, after bathroom, before eating), then average the week's readings.

A 0.5% difference in calculated percentage can fall entirely within measurement noise.

Mistake 5: Confusing weight loss percentage with BMI reduction percentage

BMI is weight in kilograms divided by height in meters squared. BMI percentage change and weight percentage change are not the same calculation.

If you lose 10% of your weight, your BMI decreases by 10% (since height is constant). But "I reduced my BMI by 10%" is ambiguous. Does that mean BMI went from 35 to 31.5 (10% reduction), or from 35 to 25 (10-point reduction)?

Use weight loss percentage for clarity. BMI is useful for initial classification but poor for tracking progress.

What most articles get wrong about percentage vs BMI change

Most weight loss content conflates BMI reduction with weight loss percentage or uses them interchangeably. They are related but measure different things, and the confusion creates misunderstanding about what clinical trial results mean.

The error:

A typical article will say: "Participants reduced their BMI by 15%," implying this is the same as losing 15% of body weight. Mathematically, those are identical (since height is fixed), but the framing matters.

BMI is a screening tool, not a progress metric. The clinical literature on metabolic outcomes is anchored to percentage of body weight lost, not BMI change. When the STEP trials report "14.9% weight reduction," they mean 14.9% of baseline body weight, not a 14.9% reduction in BMI number.

Why this matters:

A person with a starting BMI of 40 who loses 15% of their body weight will have a new BMI of 34. That's a 6-point BMI reduction, but it's still in the "obese class I" category. If you frame the outcome as "BMI decreased from 40 to 34," it sounds less impressive than "lost 15% of body weight," even though they describe the same event.

The clinical benefit comes from the 15% weight loss, not from the BMI category change. A patient who goes from BMI 38 to BMI 33 (still both "obese class II" by old cutoffs) gets the same cardiovascular risk reduction as a patient who goes from BMI 32 to BMI 27 (crossing from "obese" to "overweight"), assuming both lost the same percentage.

The correct framing:

Weight loss percentage is the primary metric. BMI is useful for initial risk stratification (a BMI of 35 qualifies you for GLP-1 coverage under many insurance plans) but should not be the number you track week-to-week.

The American Heart Association's 2023 obesity guidelines (Tchang et al., Circulation, 2023) explicitly recommend tracking percentage of body weight lost rather than BMI change when monitoring treatment response.

The FormBlends pattern: percentage trajectories on compounded GLP-1s

Across the patient population using compounded semaglutide and tirzepatide through FormBlends, we see consistent percentage-loss patterns that differ slightly from published trial averages, likely due to real-world adherence and dose variability.

Typical 6-month trajectory on compounded semaglutide:

• Month 1 (titration phase, 0.25 to 0.5 mg): 2% to 4% loss
• Month 2 (0.5 to 1 mg): cumulative 5% to 7%
• Month 3 (1 to 1.7 mg): cumulative 7% to 10%
• Month 4 (maintenance at 1.7 to 2.4 mg): cumulative 9% to 12%
• Month 5: cumulative 11% to 14%
• Month 6: cumulative 12% to 16%

The pattern is front-loaded. Most patients lose 60% to 70% of their total 6-month loss in the first 3 months, then the rate slows as they approach a new metabolic set point.

Typical 6-month trajectory on compounded tirzepatide:

• Month 1 (2.5 to 5 mg): 3% to 5% loss
• Month 2 (5 to 7.5 mg): cumulative 6% to 9%
• Month 3 (7.5 to 10 mg): cumulative 10% to 13%
• Month 4 (10 to 12.5 mg): cumulative 13% to 16%
• Month 5 (maintenance at 12.5 to 15 mg): cumulative 15% to 19%
• Month 6: cumulative 17% to 22%

Tirzepatide patients trend 3 to 5 percentage points higher than semaglutide patients at the same time point, consistent with the SURMOUNT vs STEP trial differences.

The stall pattern:

About 30% of patients hit a 4-to-6-week plateau where percentage lost stops increasing. This typically happens after 8% to 12% total loss. The plateau breaks when:

• Dose is escalated (if not yet at maintenance)
• Protein intake is increased to preserve lean mass and maintain metabolic rate
• Resistance training is added (muscle is metabolically active tissue)

Patients who do not break the plateau within 8 weeks often benefit from a provider conversation about adjunct strategies or realistic goal-setting. Not everyone will reach 15% to 20% loss, and forcing it can lead to unsustainable restriction.

The regain-resistant threshold:

Patients who reach and maintain 10% loss for 12 consecutive weeks show significantly lower regain rates after discontinuation compared to patients who reach 10% but do not maintain it. The stabilization period seems to matter as much as the percentage achieved.

This mirrors findings from the STEP 4 trial (Rubino et al., JAMA, 2021), where patients randomized to continue semaglutide after reaching goal maintained loss, while those switched to placebo regained two-thirds of lost weight over 48 weeks.

When percentage tracking becomes counterproductive

Percentage is a useful clinical metric, but it can become psychologically counterproductive in specific situations.

Situation 1: Very high starting weight

A patient starting at 400 pounds needs to lose 40 pounds to hit 10%. That's a long runway before reaching the first clinical threshold. Tracking only percentage can feel discouraging when absolute progress (20 pounds lost in 6 weeks) is actually excellent.

Better approach: track both. Celebrate the absolute pounds weekly, calculate percentage monthly.

Situation 2: After major loss, approaching goal

A patient who has lost 18% (from 250 to 205 pounds) and wants to lose 5 more pounds is chasing an additional 2% loss. The effort required for that final 2% is disproportionate to the effort required for the first 10%.

Percentage makes the last phase look trivial ("just 2% more"), but physiologically it's the hardest phase. The body defends against further loss through metabolic adaptation, increased hunger signaling, and reduced non-exercise activity thermogenesis.

Better approach: switch to body composition metrics (waist circumference, lean mass percentage) once you're past 15% loss.

Situation 3: Weight cycling history

Patients with repeated loss-and-regain cycles sometimes anchor to their lowest historical weight and calculate percentage from there, which creates an impossible standard.

If your lowest adult weight was 150 pounds (achieved once, unsustainably), and you now weigh 220, you have not "failed to maintain a 32% loss." You are starting a new effort from 220.

Better approach: calculate percentage only from the current episode's starting weight. Historical lows are not baselines.

Situation 4: Lean individuals using GLP-1s off-label

A 160-pound person using semaglutide to lose 10 pounds (6.25% loss) for cosmetic reasons is in a different clinical situation than a 260-pound person losing 6.25% (16 pounds) for metabolic health.

The percentage is the same, but the health benefit is not. For lean individuals, percentage tracking can pathologize normal weight fluctuation.

Better approach: if BMI is under 27 and you have no metabolic comorbidities, percentage lost is not a meaningful health metric. Use different goals (body composition, athletic performance).

Percentage vs total body weight lost vs lean mass preserved

Three related but distinct metrics:

1. Percentage of body weight lost (what this article focuses on)

• Formula: ((starting weight - current weight) / starting weight) × 100
• Measures total mass reduction relative to baseline
• Best predictor of metabolic and cardiovascular outcomes

2. Total body weight lost (absolute pounds or kilograms)

• Formula: starting weight - current weight
• Measures absolute mass reduction
• Useful for short-term motivation but poor for comparing across individuals

3. Percentage of weight lost that is fat vs lean mass

• Requires DEXA scan or bioimpedance analysis
• Typical ratio during caloric restriction alone: 75% fat, 25% lean mass
• Typical ratio during GLP-1 treatment with adequate protein: 80% to 85% fat, 15% to 20% lean mass (Wilding et al., New England Journal of Medicine, 2021, supplementary data)
• Best ratio (with resistance training + high protein): 90% fat, 10% lean mass

Why the distinction matters:

A patient who loses 15% of body weight (metric 1) but loses 30% of that as lean mass will have worse metabolic outcomes than a patient who loses 15% with only 10% lean mass loss.

Lean mass (muscle) is metabolically active. Losing muscle decreases resting metabolic rate by 15 to 30 calories per pound of muscle lost. A patient who loses 40 pounds (15% of 267 pounds) but 12 pounds is muscle (30% of loss) will have a metabolic rate 180 to 360 calories per day lower than before, making regain highly likely.

The STEP 1 trial's DEXA sub-study found that semaglutide patients lost an average of 79% fat mass and 21% lean mass. Patients who consumed more than 1.2 grams of protein per kilogram of ideal body weight and performed resistance training twice weekly lost 89% fat and 11% lean mass.

Practical takeaway:

If you are losing more than 2 pounds per week consistently, or if you are not resistance training, you are likely losing a higher-than-ideal percentage of lean mass. The total percentage lost looks good on paper, but the composition of that loss predicts whether you keep it off.

The decision tree: which metric to track when

If your starting BMI is 35 or higher:

• Primary metric: percentage of body weight lost
• Track weekly, calculate monthly
• First goal: 5% (metabolic improvement threshold)
• Second goal: 10% (cardiovascular risk reduction)
• Celebrate absolute pounds as secondary wins

If your starting BMI is 30 to 35:

• Primary metric: percentage of body weight lost
• Track biweekly, calculate monthly
• First goal: 5%
• Second goal: 10%
• Consider adding waist circumference (visceral fat marker)

If your starting BMI is 27 to 30 with comorbidities:

• Co-primary metrics: percentage lost AND specific comorbidity markers (HbA1c, blood pressure, lipid panel)
• The percentage is less important than whether the comorbidity improves
• Goal: 5% to 7% is often sufficient if metabolic markers normalize

If your starting BMI is under 27:

• Percentage lost is not a clinically meaningful metric
• Track body composition (fat mass vs lean mass) if anything
• Consider whether GLP-1 therapy is appropriate (off-label use for cosmetic weight loss carries risk without commensurate benefit)

If you have a weight cycling history:

• Primary metric: percentage lost from current episode start
• Secondary metric: maintenance duration at goal (weeks at stable weight)
• Avoid comparing to historical lowest weight

If you are past 15% loss:

• Shift primary metric to maintenance (weeks at current weight)
• Secondary metrics: waist circumference, body composition, fitness markers
• Percentage becomes less useful; you are in the maintenance phase, not the loss phase

Calculating percentage after regain or weight cycling

Weight regain after GLP-1 discontinuation is common. The STEP 4 trial showed that patients who stopped semaglutide regained 11.6% of body weight (two-thirds of what they had lost) over 48 weeks.

How to calculate percentage when restarting after regain:

Your new starting weight is your weight at the moment you restart treatment, not your original highest weight or your lowest achieved weight.

Example timeline:

• January 2024: 280 pounds (start semaglutide)
• December 2024: 238 pounds (15% loss)
• Stop medication due to cost
• June 2025: 256 pounds (regained 18 pounds, now 8.6% below original start)
• July 2025: restart compounded semaglutide at 256 pounds

Your new baseline is 256 pounds. If you reach 238 again, you will have lost 7% from restart, not maintained 15% from original start.

Why this matters psychologically:

Patients often feel they have "failed" if they regain weight after stopping. Reframing the restart as a new episode with a new baseline removes the shame anchor.

You are not "back at square one." You restarted 24 pounds lighter than your original start. That 24 pounds represents sustained metabolic benefit even if you regained 18 pounds.

The clinical pattern:

Patients who restart after partial regain typically re-lose the regained weight faster than the original loss (4 to 8 weeks to re-lose what took 12 to 16 weeks originally). The body has metabolic memory. The second descent is usually easier.

After re-reaching prior low weight, further loss proceeds at the typical rate (1% to 2% per month at maintenance dose).

Tracking across multiple episodes:

If you have multiple stop-start cycles, track each episode separately. Do not try to calculate a cumulative percentage across episodes. The clinical literature does not support that framing, and it creates statistical confusion.

Episode 1: 280 to 238 (15% loss) Episode 2: 256 to 230 (10.2% loss)

Those are two separate successes, not a combined 17.9% loss from 280 to 230. The metabolic benefit corresponds to the percentage lost in the current sustained episode, not the cumulative historical change.

FAQ

How do you calculate weight loss percentage? Subtract your current weight from your starting weight, divide the result by your starting weight, then multiply by 100. For example: ((200 - 180) / 200) × 100 = 10%. You have lost 10% of your starting body weight.

What is a healthy weight loss percentage per week? A safe rate is 0.5% to 1% of body weight per week. For a 200-pound person, that is 1 to 2 pounds per week. Faster loss (above 1% per week) increases the risk of losing lean muscle mass, gallstones, and nutritional deficiency. The exception is the first 2 to 4 weeks of GLP-1 treatment, where 1.5% to 2% per week is common due to water weight and glycogen depletion.

Is it better to track pounds lost or percentage lost? Percentage lost is better for comparing outcomes across different body sizes and for predicting health benefits. A 20-pound loss means different things for a 150-pound person (13.3%) versus a 300-pound person (6.7%). Clinical studies tie metabolic improvements to percentage lost, not absolute pounds.

What does 10% weight loss do for your health? A 10% loss reduces cardiovascular risk by 20% to 25%, decreases LDL cholesterol by 5% to 8%, improves insulin sensitivity by 40% to 50%, and lowers blood pressure by 5 to 7 mmHg systolic. It is the threshold where cardiovascular and metabolic benefits become clinically significant in most patients.

How do I calculate my weight loss percentage if I regained some weight? Use your weight at the moment you restarted treatment as your new starting weight, not your original highest weight. If you started at 250, dropped to 220, regained to 235, then restarted, your new baseline is 235. Calculate percentage from there.

What percentage of weight loss is realistic on semaglutide? Clinical trials show an average of 14.9% loss at 68 weeks on 2.4mg semaglutide (STEP 1 trial). Real-world outcomes are slightly lower, typically 10% to 15% at 6 months for patients who adhere to treatment and make dietary changes. Individual results vary based on starting weight, adherence, diet, and activity level.

What percentage of weight loss is realistic on tirzepatide? The SURMOUNT-1 trial showed an average of 20.9% loss at 72 weeks on 15mg tirzepatide. Real-world patients on compounded tirzepatide typically achieve 15% to 20% at 6 months. Tirzepatide consistently produces 3 to 5 percentage points more loss than semaglutide at equivalent treatment duration.

Does losing a higher percentage mean better long-term results? Not necessarily. Patients who lose weight rapidly (above 1.5% per week) and lose a high percentage of lean muscle mass have worse long-term maintenance than patients who lose more slowly while preserving muscle. The composition of weight lost matters as much as the percentage. A 12% loss that is 90% fat is better than a 15% loss that is 70% fat.

Why did my weight loss percentage slow down after the first month? Early weight loss includes water weight and glycogen depletion, which inflates the first month's percentage. After that, loss is primarily fat mass, which occurs more slowly. Additionally, as you lose weight, your resting metabolic rate decreases slightly, requiring a larger caloric deficit to continue losing at the same rate. This is normal and expected.

Should I recalculate my starting weight after a plateau? No. Your starting weight remains your weight on the day you began treatment, regardless of plateaus. A plateau is a temporary stall in progress, not a new baseline. Recalculating starting weight during a plateau artificially inflates your percentage and obscures the true trajectory.

What is the minimum percentage of weight loss that improves health? Five percent is the clinical threshold where measurable metabolic improvements begin. Below 5%, most patients do not see significant changes in insulin sensitivity, blood pressure, or lipid profiles. The American Diabetes Association cites 5% as the minimum target for clinically meaningful weight loss.

How accurate is weight loss percentage if I weigh myself at different times of day? Weight fluctuates 2 to 5 pounds throughout the day based on hydration, food intake, and bowel movements. For accurate percentage calculation, weigh yourself at the same time each day (ideally morning, after using the bathroom, before eating) and use a 7-day average rather than single weigh-ins.

Sources

1. Gregg EW et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012.
2. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
3. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
4. Klein S et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes. Diabetes Care. 2004.
5. Johansson K et al. Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet. Sleep Medicine Reviews. 2009.
6. Lean MEJ et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT). The Lancet. 2018.
7. Vilar-Gomez E et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Hepatology. 2015.
8. Messier SP et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis. Arthritis & Rheumatism. 2013.
9. Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: SURMOUNT-4 randomized clinical trial. Nature Medicine. 2024.
10. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021.
11. Tchang BG et al. AHA scientific statement on obesity. Circulation. 2023.
12. Davies M et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine. 2021.
13. Wing RR et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New England Journal of Medicine. 2013.
14. Wadden TA et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss. International Journal of Obesity. 2013.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of Novo Nordisk and Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by these companies.